HPLC-API/MS/MS: a powerful tool for integrating drug metabolism into the drug discovery process

被引:91
|
作者
Korfmacher, WA [1 ]
Cox, KA [1 ]
Bryant, MS [1 ]
Veals, J [1 ]
Ng, K [1 ]
Watkins, R [1 ]
Lin, CC [1 ]
机构
[1] SCHERING PLOUGH CORP,RES INST,DEPT PHARMACOL,KENILWORTH,NJ 07033
关键词
D O I
10.1016/S1359-6446(97)01121-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
HPLC combined with atmospheric pressure ionization (API) mass spectrometry (MS) has become a very useful tool in the pharmaceutical industry. The technique of HPLC-API/MS/MS is becoming very important for both drug discovery and drug development programs. In the drug discovery area, it has three major uses: (1) rapid, quantitative method development, (2) metabolite identification, and (3) multi-drug analysis. The sensitivity of the API source and the selectivity provided by tandem mass spectrometry (MS/MS) enable rapid, quantitative method development for drugs in plasma. Early information on the metabolism of candidate drugs can guide structural modifications, thereby improving the activity and/or bioavailability.
引用
收藏
页码:532 / 537
页数:10
相关论文
共 50 条
  • [41] Development of a drug discovery pipeline for secondary progressive MS
    Quintana, F. J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 15 - 15
  • [42] Disability Specific Drug Discovery in MS: Focus on Vision
    Tassoni, Alessia
    Itoh, Yuichiro
    Itoh, Noriko
    Farkhondeh, Vista
    Sofroniew, Michael
    Voskuhl, Rhonda
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 5 - 6
  • [43] Determination of 80 Veterinary Drug Residues and Their Metabolites in Beef by HPLC-MS/MS
    Li, Yongqin
    Bu, Ningxia
    Chen, Juan
    Ma, Yan
    Yang, Qi
    Journal of Food Science and Technology (China), 2022, 40 (01): : 140 - 149
  • [44] Automated sample preparation and GC-API-MS/MS as a powerful tool for analysis of legacy POPs in human serum and plasma
    Huber, Sandra
    Averina, Maria
    Brox, Jan
    ANALYTICAL METHODS, 2020, 12 (07) : 912 - 929
  • [45] Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery
    Chen, Kuanchang
    Dores-Sousa, Jose Luis
    Fontana, Alberto
    Grosanu, Cristina
    Mcallister, Heather M.
    Bai, Guoyun
    Bartkowiak, Karolina
    Canellas, Santiago
    Corens, David
    De Groot, Alex
    Nevarez, Juan
    Serrano, Marta
    Raeymaekers, Kristien
    Rodriguez, Raquel
    Van Eynde, Lars
    Zhou, Ronghui
    Shi, Zhicai
    JOURNAL OF CHROMATOGRAPHY A, 2025, 1742
  • [46] HPLC/ICP-MS in Combination with "Reverse" Online Isotope Dilution in Drug Metabolism Studies
    Meermann, Bjoern
    Hulstaert, Anne
    Laenen, Aline
    Van Looveren, Cis
    Vliegen, Maarten
    Cuyckens, Filip
    Vanhaecke, Frank
    ANALYTICAL CHEMISTRY, 2012, 84 (05) : 2395 - 2401
  • [47] Authentication of two eighteenth century juniper-containing drug remains by HPLC–MS/MS and GC–MS
    Karel Nesměrák
    Tomáš Lener
    Anton Korban
    Martin Štícha
    Monatshefte für Chemie - Chemical Monthly, 2023, 154 : 977 - 986
  • [48] MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery
    Wang, Yijia
    Hummon, Amanda B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (04)
  • [49] Determination of thirteen antibiotics in drug products - A new LC-MS/MS tool for screening drug product quality
    Bekoe, Samuel Oppong
    Bak, Soren Alex
    Bjorklund, Erland
    Krogh, Kristine A.
    Okine, Nathaniel N. N. A.
    Adosraku, Reimmiel K.
    Styrishave, Bjarne
    Hansen, Martin
    ANALYTICAL METHODS, 2014, 6 (15) : 5847 - 5855
  • [50] Microsomal metabolism of calycosin, formononetin and drug-drug interactions by dynamic microdialysis sampling and HPLC-DAD-MS analysis
    Wen, Xiao-Dong
    Qi, Lian-Wen
    Li, Bin
    Li, Ping
    Yi, Ling
    Wang, Ya-Qiong
    Liu, E-Hu
    Yang, Xiao-Lin
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 50 (01) : 100 - 105